Gibson Christopher Insider Trading Activity

Average Profitability
<0.0001%
Insider Buys Quantity
0
Insider Buys Sum
$0
Insider Sells Quantity
80
Insider Sells Sum
$39.19M

Insider Activity of Gibson Christopher

According to the SEC Form 4 filings, Gibson Christopher, being in a position of

  1. director at Recursion Pharmaceuticals, Inc.,
    оver the last 12 months, has bought 0 shares, and sold 560000 shares for $2.19M,
    over all time since 2021-12-07, has bought 0 shares, and sold 5808527 shares for $46.15M.

Biography of Gibson Christopher

No biography is available at this moment.

Statistics of Insider Transactions Last Year

Amount of Insider Buys and Sells by Stocks

Buys
 $000
Sells
 $2,193,20014100

Comparison of Insiders on Amount of Buys and Sells

2026-06-05SaleRecursion Pharmaceuticals, Inc.
RXRX
director
40,000
0.0085%
$3.62$144,800+3.16%
2026-05-22SaleRecursion Pharmaceuticals, Inc.
RXRX
director
40,000
0.0092%
$3.08$123,200+14.29%
2026-05-07SaleRecursion Pharmaceuticals, Inc.
RXRX
director
40,000
0.0092%
$3.37$134,800+2.29%
2026-04-22SaleRecursion Pharmaceuticals, Inc.
RXRX
director
40,000
0.0087%
$3.61$144,400-9.12%
2026-04-07SaleRecursion Pharmaceuticals, Inc.
RXRX
director
40,000
0.0087%
$3.10$124,000+6.9%
2026-03-23SaleRecursion Pharmaceuticals, Inc.
RXRX
director
40,000
0.009%
$3.25$130,000+4.49%
2026-02-19SaleRecursion Pharmaceuticals, Inc.
RXRX
director
40,000
0.0098%
$3.46$138,400-8.33%
2026-02-04SaleRecursion Pharmaceuticals, Inc.
RXRX
director
40,000
0.0105%
$4.12$164,800-12.31%
2026-01-20SaleRecursion Pharmaceuticals, Inc.
RXRX
director
40,000
0.0101%
$4.47$178,800-21.82%
2026-01-05SaleRecursion Pharmaceuticals, Inc.
RXRX
director
40,000
0.0097%
$4.25$170,000-20.82%
2025-12-19SaleRecursion Pharmaceuticals, Inc.
RXRX
Chief Executive Officer
40,000
0.0105%
$4.50$180,000-18.08%
2025-12-04SaleRecursion Pharmaceuticals, Inc.
RXRX
Chief Executive Officer
40,000
0.0094%
$4.63$185,200-28.66%
2025-11-19SaleRecursion Pharmaceuticals, Inc.
RXRX
Chief Executive Officer
40,000
0.0103%
$4.16$166,400-12.16%
2025-11-04SaleRecursion Pharmaceuticals, Inc.
RXRX
Chief Executive Officer
40,000
0.0088%
$5.21$208,400-28.8%
2025-10-10SaleRecursion Pharmaceuticals, Inc.
RXRX
Chief Executive Officer
100,000
0.0264%
$6.04$604,000-33.08%
2025-09-25SaleRecursion Pharmaceuticals, Inc.
RXRX
Chief Executive Officer
100,000
0.0227%
$4.76$476,000-23.11%
2025-09-10SaleRecursion Pharmaceuticals, Inc.
RXRX
Chief Executive Officer
100,000
0.0243%
$4.71$471,000-20.04%
2025-08-26SaleRecursion Pharmaceuticals, Inc.
RXRX
Chief Executive Officer
100,000
0.0229%
$4.84$484,000-22.98%
2025-08-11SaleRecursion Pharmaceuticals, Inc.
RXRX
Chief Executive Officer
518,175
0.121%
$5.28$2.74M-27.22%
2025-03-27SaleRecursion Pharmaceuticals, Inc.
RXRX
Chief Executive Officer
138,574
0.0355%
$6.04$836,987-20.77%
Total: 99
Company
About Prismo.proIdeasArticlesPrivacy PolicyTerms of ServiceContact Us
Screener Ideas
Dividend StocksBlue Chip StocksDefensive StocksGrowth StocksValue StocksCyclical StocksPenny Stocks
Stock Tools
Insiders ScreenerStocks ScreenerTop StocksStock NewsInsider RatioList of All Stocks
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.